Biomarkers of disease progression in people with psoriasis: a scoping review

BACKGROUND: Identification of those at risk of more severe psoriasis and/or associated morbidities offers opportunity for early intervention, reduced disease burden and more cost‐effective healthcare. Prognostic biomarkers of disease progression have thus been the focus of intense research, but none...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramessur, Ravi, Corbett, Mark, Marshall, David, Acencio, Marcio L., Barbosa, Ines A., Dand, Nick, Di Meglio, Paola, Haddad, Salma, Jensen, Andreas H.M., Koopmann, Witte, Mahil, Satveer K., Ostaszewski, Marek, Rahmatulla, Seher, Rastrick, Joe, Saklatvala, Jake, Weidinger, Stephan, Wright, Kath, Eyerich, Kilian, Ndlovu, Matladi, Barker, Jonathan N., Skov, Lone, Conrad, Curdin, Smith, Catherine H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Evidence‐Based Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796834/
https://www.ncbi.nlm.nih.gov/pubmed/35482474
http://dx.doi.org/10.1111/bjd.21627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796834/
https://www.ncbi.nlm.nih.gov/pubmed/35482474
http://dx.doi.org/10.1111/bjd.21627

Ejemplares similares